Block of calcium channels by enkephalin and somatostatin in neuroblastoma-glioma hybrid NG108-15 cells.
Leucine-enkephalin, methionine-enkephalin, and morphine caused a reversible block of Ca2+ channel currents in neuroblastoma-glioma hybrid cells (NG108-15). The long-lasting (type 2) component of the Ca2+ channel current was blocked by leucine-enkephalin, while the transient (type 1) component was not affected. The enkephalin-induced blocking action was antagonized by naloxone and appears to be mediated by delta-opiate receptors. Two different aspects of the blocking effect were detected, a resting block and a recovery from block during prolonged depolarizing pulses. Recovery from block was more complete, and its time course was more rapid, with depolarization to more positive potentials. The dose dependence of the type 2 channel block at rest indicated a one-to-one binding stoichiometry, with an apparent dissociation constant of 8.8 nM. Somatostatin exerted a similar selective blocking action on the type 2 Ca2+ channel. The time- and voltage-dependent block of type 2 Ca2+ channels may provide a mechanism underlying the enkephalinergic presynaptic inhibition of transmitter release and the somatostatin block of pituitary growth hormone release.
D000818:Animals; D002118:Calcium / Q000502:physiology*; D002121:Calcium Channel Blockers; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D004553:Electric Conductivity; D004743:Enkephalin, Leucine / Q000494:pharmacology*; D005910:Glioma; D007473:Ion Channels / Q000145:classification / Q000187:drug effects / Q000502:physiology*; D009270:Naloxone / Q000494:pharmacology; D009447:Neuroblastoma; D051381:Rats; D013004:Somatostatin / Q000494:pharmacology*
D002121:Calcium Channel Blockers; D007473:Ion Channels; D009270:Naloxone; D013004:Somatostatin; D004743:Enkephalin, Leucine; D002118:Calcium